These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8602768)

  • 21. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
    Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele.
    Riemenschneider M; Schwarz S; Wagenpfeil S; Diehl J; Müller U; Förstl H; Kurz A
    Mol Psychiatry; 2002; 7(7):782-5. PubMed ID: 12192623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E epsilon2 does not increase risk of early-onset sporadic Alzheimer's disease.
    Scott WK; Saunders AM; Gaskell PC; Locke PA; Growdon JH; Farrer LA; Auerbach SA; Roses AD; Haines JL; Pericak-Vance MA
    Ann Neurol; 1997 Sep; 42(3):376-8. PubMed ID: 9307262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic factors in Alzheimer's disease.
    Bird TD
    N Engl J Med; 2005 Mar; 352(9):862-4. PubMed ID: 15745976
    [No Abstract]   [Full Text] [Related]  

  • 25. Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: a cautionary view.
    Kakulas BA; van Bockxmeer FM
    Ann Neurol; 1995 Dec; 38(6):966-7. PubMed ID: 8526475
    [No Abstract]   [Full Text] [Related]  

  • 26. Apolipoprotein E genotype and Alzheimer's disease. Alzheimer's Disease Collaborative Group.
    Lancet; 1993 Sep; 342(8873):737-8. PubMed ID: 8103833
    [No Abstract]   [Full Text] [Related]  

  • 27. Ageing matters. Genetic link to Alzheimer's.
    Isaacs R; Roquew P
    Nurs Times; 1995 Apr 26-May 2; 91(17):61-3. PubMed ID: 7753666
    [No Abstract]   [Full Text] [Related]  

  • 28. K variant of butyrycholinesterase and late-onset Alzheimer's disease.
    Russ C; Powell J; Lovestone S; Holmes C
    Lancet; 1998 Mar; 351(9106):881. PubMed ID: 9525372
    [No Abstract]   [Full Text] [Related]  

  • 29. The apolipoprotein E E4 allele and sex-specific risk of Alzheimer's disease.
    Corder EH; Saunders AM; Strittmatter WJ; Schmechel DE; Gaskell PC; Roses AD; Pericak-Vance MA; Small GW; Haines JL
    JAMA; 1995 Feb; 273(5):373-4. PubMed ID: 7823376
    [No Abstract]   [Full Text] [Related]  

  • 30. Age of onset in patients with Alzheimer's disease with different apoE genotypes.
    do Couto FS; de Mendonça A; Garcia C; Rocha L; Lechner MC
    J Neurol Neurosurg Psychiatry; 1998 Jun; 64(6):817. PubMed ID: 9647321
    [No Abstract]   [Full Text] [Related]  

  • 31. Screening for Alzheimer's disease.
    Krause A; Jenkins T
    S Afr Med J; 1997 Feb; 87(2):128-30. PubMed ID: 9107213
    [No Abstract]   [Full Text] [Related]  

  • 32. [Alzheimer disease. Strong connection between apolipoprotein E and disease development].
    Lannfelt L; Basun H; Winblad B
    Lakartidningen; 1994 Apr; 91(15):1500-2. PubMed ID: 8183036
    [No Abstract]   [Full Text] [Related]  

  • 33. Apolipoprotein E genotyping in Alzheimer's disease. National Institute on Aging/Alzheimer's Association Working Group.
    Lancet; 1996 Apr; 347(9008):1091-5. PubMed ID: 8602063
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical application of apolipoprotein E genotyping to Alzheimer's disease.
    Roses AD; Strittmatter WJ; Pericak-Vance MA; Corder EH; Saunders AM; Schmechel DE
    Lancet; 1994 Jun; 343(8912):1564-5. PubMed ID: 7911881
    [No Abstract]   [Full Text] [Related]  

  • 35. Apolipoprotein E genotyping in Alzheimer's disease. The UK Alzheimer's Disease Genetic consortium.
    Lovestone S; Wilcock G; Rossor M; Cayton H; Ragan I
    Lancet; 1996 Jun; 347(9017):1775-6. PubMed ID: 8656944
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of apolipoprotein E genotype for preclinical detection of risk's group for Alzheimer's disease.
    Oliveira JR; Lima Filho JL; Shimokomaki CM; Okuma M; Passos-Bueno MR; Zatz M; Brito-Marques PR
    Am J Med Genet; 1997 Apr; 74(2):216-7. PubMed ID: 9129729
    [No Abstract]   [Full Text] [Related]  

  • 37. [Molecular pathogenesis of Alzheimer's disease].
    Yanagisawa K
    Nihon Ronen Igakkai Zasshi; 2001 Sep; 38(5):617-8. PubMed ID: 11605204
    [No Abstract]   [Full Text] [Related]  

  • 38. Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease.
    Kamboh MI; DeKosky ST
    Ann Neurol; 1995 Dec; 38(6):967-70. PubMed ID: 8526476
    [No Abstract]   [Full Text] [Related]  

  • 39. Apolipoprotein E genotype: utility in clinical practice in Alzheimer's disease.
    Hyman BT
    J Am Geriatr Soc; 1996 Dec; 44(12):1469-71. PubMed ID: 8951318
    [No Abstract]   [Full Text] [Related]  

  • 40. NIA/AIzA Conference on apolipoprotein E genotyping in Alzheimer's disease. Bibliography.
    Kwon YJ; Tsai J; Relkin NR
    Ann N Y Acad Sci; 1996 Dec; 802():177-224. PubMed ID: 9012315
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.